These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis. Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494 [TBL] [Abstract][Full Text] [Related]
5. New amino acid esters of salicylanilides active against MDR-TB and other microbes. Krátký M; Vinšová J; Buchta V; Horvati K; Bösze S; Stolaříková J Eur J Med Chem; 2010 Dec; 45(12):6106-13. PubMed ID: 20937542 [TBL] [Abstract][Full Text] [Related]
6. Phenolic N-monosubstituted carbamates: Antitubercular and toxicity evaluation of multi-targeting compounds. Krátký M; Janďourek O; Baranyai Z; Novotná E; Stolaříková J; Bősze S; Vinšová J Eur J Med Chem; 2019 Nov; 181():111578. PubMed ID: 31401536 [TBL] [Abstract][Full Text] [Related]
7. Antimycobacterial assessment of Salicylanilide benzoates including multidrug-resistant tuberculosis strains. Krátký M; Vinšová J; Stolaříková J Molecules; 2012 Oct; 17(11):12812-20. PubMed ID: 23114617 [TBL] [Abstract][Full Text] [Related]